MedTrace Logo

Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

NCT01820962 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 212

Last updated 2013-03-29

No results posted yet for this study

Summary

Patients with a hematological malignancy who are undergoing intensive chemotherapy need a central venous catheter (CVC)during their treatment. CVCs are locked with heparin when they are not used.

The purpose of this study is to determine whether concentrated citrate locking, compared to heparin, reduces the incidence of central venous catheter-related thrombosis and infections in patients with hematological malignancies undergoing intensive chemotherapy.

Conditions

Interventions

PROCEDURE

heparin

when not in use CVCs are locked with heparin

PROCEDURE

concentrated citrate

when not in use the CVC is locked with concentrated citrate

Sponsors & Collaborators

  • Dirinco B.V.

    collaborator INDUSTRY

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Harry Schouten, MD · Maastricht University Medical Centre

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2010-12-31
Completion
2012-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01820962 on ClinicalTrials.gov